Suche senden
Hochladen
Rosuvastatin, pcsk9 concentrations, and ldl cholesterol response the jupiter trial
•
4 gefällt mir
•
1,002 views
King Abdulaziz University - Jeddah
Folgen
Business
Technologie
Melden
Teilen
Melden
Teilen
1 von 16
Jetzt herunterladen
Downloaden Sie, um offline zu lesen
Empfohlen
Crestor Presentation
Crestor Presentation
hospital
ueda2013 primary prevention-d.lobna
ueda2013 primary prevention-d.lobna
ueda2015
Atorvastatin
Atorvastatin
kenny_gwc
Statin combinations
Statin combinations
cardiositeindia
Lipid lowering trials ppt
Lipid lowering trials ppt
Navin Agrawal
Statins-cornerstone in lipid management
Statins-cornerstone in lipid management
LPS Institute of Cardiology Kanpur UP India
Jupiter Slides translate
Jupiter Slides translate
guestef55fa
Statins+in+ACS
Statins+in+ACS
dhavalshah4424
Empfohlen
Crestor Presentation
Crestor Presentation
hospital
ueda2013 primary prevention-d.lobna
ueda2013 primary prevention-d.lobna
ueda2015
Atorvastatin
Atorvastatin
kenny_gwc
Statin combinations
Statin combinations
cardiositeindia
Lipid lowering trials ppt
Lipid lowering trials ppt
Navin Agrawal
Statins-cornerstone in lipid management
Statins-cornerstone in lipid management
LPS Institute of Cardiology Kanpur UP India
Jupiter Slides translate
Jupiter Slides translate
guestef55fa
Statins+in+ACS
Statins+in+ACS
dhavalshah4424
Role of Statin in Secondary Prevention of ACS
Role of Statin in Secondary Prevention of ACS
PERKI Pekanbaru
Old vs new targets april 2015
Old vs new targets april 2015
Henry Tran
JUPITER (Justification for the Use of Statins in Primary Prevention: An Inter...
JUPITER (Justification for the Use of Statins in Primary Prevention: An Inter...
theheart.org
Statin Wars
Statin Wars
Harvard Medical School, LMU Munich
14.09.13 high dose statin
14.09.13 high dose statin
Rajeev Agarwala
Dyslipidemia management an evidence based approach
Dyslipidemia management an evidence based approach
Dr Vivek Baliga
Rosuvastatin
Rosuvastatin
Jahanzaib Sheikh
Dyslipidemia 2016
Dyslipidemia 2016
PHAM HUU THAI
Statins 5-15
Statins 5-15
qualityinhealth
Statin drugs are they worth the risks
Statin drugs are they worth the risks
DIPAK PATADE
Statin Use and Diabetes Risk
Statin Use and Diabetes Risk
Linh Huynh, PharmD
Current Controversies in Dyslipidemia Management:
Current Controversies in Dyslipidemia Management:
magdy elmasry
Treatment strategies in patients with statin intolerance
Treatment strategies in patients with statin intolerance
Vishwanath Hesarur
Atorvastatin: Statins in CVD management. Is just lipid lowering enough
Atorvastatin: Statins in CVD management. Is just lipid lowering enough
Dr Vivek Baliga
211 statin therapy
211 statin therapy
Society for Heart Attack Prevention and Eradication
What is hyperlipidemia
What is hyperlipidemia
Christi Mamdouh
Evolocumab PCSK9 inhibitor
Evolocumab PCSK9 inhibitor
Sara Temkit
ATP IV Guideline for Blood cholesterol level
ATP IV Guideline for Blood cholesterol level
kamalmodi481
PCKS9 INHIBITORS
PCKS9 INHIBITORS
Shivani Rao
Strategy to Go for Goal in Dyslipidemia with Acute Coronary Syndrome Patients
Strategy to Go for Goal in Dyslipidemia with Acute Coronary Syndrome Patients
PERKI Pekanbaru
Chasman
Chasman
The Ohio State University Wexner Medical Center
Immunocal Lung Cancer Ars
Immunocal Lung Cancer Ars
Avis Betancourt
Weitere ähnliche Inhalte
Was ist angesagt?
Role of Statin in Secondary Prevention of ACS
Role of Statin in Secondary Prevention of ACS
PERKI Pekanbaru
Old vs new targets april 2015
Old vs new targets april 2015
Henry Tran
JUPITER (Justification for the Use of Statins in Primary Prevention: An Inter...
JUPITER (Justification for the Use of Statins in Primary Prevention: An Inter...
theheart.org
Statin Wars
Statin Wars
Harvard Medical School, LMU Munich
14.09.13 high dose statin
14.09.13 high dose statin
Rajeev Agarwala
Dyslipidemia management an evidence based approach
Dyslipidemia management an evidence based approach
Dr Vivek Baliga
Rosuvastatin
Rosuvastatin
Jahanzaib Sheikh
Dyslipidemia 2016
Dyslipidemia 2016
PHAM HUU THAI
Statins 5-15
Statins 5-15
qualityinhealth
Statin drugs are they worth the risks
Statin drugs are they worth the risks
DIPAK PATADE
Statin Use and Diabetes Risk
Statin Use and Diabetes Risk
Linh Huynh, PharmD
Current Controversies in Dyslipidemia Management:
Current Controversies in Dyslipidemia Management:
magdy elmasry
Treatment strategies in patients with statin intolerance
Treatment strategies in patients with statin intolerance
Vishwanath Hesarur
Atorvastatin: Statins in CVD management. Is just lipid lowering enough
Atorvastatin: Statins in CVD management. Is just lipid lowering enough
Dr Vivek Baliga
211 statin therapy
211 statin therapy
Society for Heart Attack Prevention and Eradication
What is hyperlipidemia
What is hyperlipidemia
Christi Mamdouh
Evolocumab PCSK9 inhibitor
Evolocumab PCSK9 inhibitor
Sara Temkit
ATP IV Guideline for Blood cholesterol level
ATP IV Guideline for Blood cholesterol level
kamalmodi481
PCKS9 INHIBITORS
PCKS9 INHIBITORS
Shivani Rao
Strategy to Go for Goal in Dyslipidemia with Acute Coronary Syndrome Patients
Strategy to Go for Goal in Dyslipidemia with Acute Coronary Syndrome Patients
PERKI Pekanbaru
Was ist angesagt?
(20)
Role of Statin in Secondary Prevention of ACS
Role of Statin in Secondary Prevention of ACS
Old vs new targets april 2015
Old vs new targets april 2015
JUPITER (Justification for the Use of Statins in Primary Prevention: An Inter...
JUPITER (Justification for the Use of Statins in Primary Prevention: An Inter...
Statin Wars
Statin Wars
14.09.13 high dose statin
14.09.13 high dose statin
Dyslipidemia management an evidence based approach
Dyslipidemia management an evidence based approach
Rosuvastatin
Rosuvastatin
Dyslipidemia 2016
Dyslipidemia 2016
Statins 5-15
Statins 5-15
Statin drugs are they worth the risks
Statin drugs are they worth the risks
Statin Use and Diabetes Risk
Statin Use and Diabetes Risk
Current Controversies in Dyslipidemia Management:
Current Controversies in Dyslipidemia Management:
Treatment strategies in patients with statin intolerance
Treatment strategies in patients with statin intolerance
Atorvastatin: Statins in CVD management. Is just lipid lowering enough
Atorvastatin: Statins in CVD management. Is just lipid lowering enough
211 statin therapy
211 statin therapy
What is hyperlipidemia
What is hyperlipidemia
Evolocumab PCSK9 inhibitor
Evolocumab PCSK9 inhibitor
ATP IV Guideline for Blood cholesterol level
ATP IV Guideline for Blood cholesterol level
PCKS9 INHIBITORS
PCKS9 INHIBITORS
Strategy to Go for Goal in Dyslipidemia with Acute Coronary Syndrome Patients
Strategy to Go for Goal in Dyslipidemia with Acute Coronary Syndrome Patients
Ähnlich wie Rosuvastatin, pcsk9 concentrations, and ldl cholesterol response the jupiter trial
Chasman
Chasman
The Ohio State University Wexner Medical Center
Immunocal Lung Cancer Ars
Immunocal Lung Cancer Ars
Avis Betancourt
3-D QSAR studies on maslinic acid analogs
3-D QSAR studies on maslinic acid analogs
Neha Dhiman
Nrcar interactive dyslipidaemia_poster
Nrcar interactive dyslipidaemia_poster
Elsa von Licy
Nrcar dyslipidaemia poster_web
Nrcar dyslipidaemia poster_web
Elsa von Licy
Pcsk9 inhibitors thesis defence
Pcsk9 inhibitors thesis defence
Naseem Badarna
Target ldl levels in extreme high risk acs. acheiving the goal
Target ldl levels in extreme high risk acs. acheiving the goal
Dr MD TALHA KHAN ABID
Shu
Shu
University of Maryland Baltimore
Drug drug gene interactions
Drug drug gene interactions
DRMOHITKHER
KATP Channel Activation by Statins Decreases Intra-Ocular Pressure. Should We...
KATP Channel Activation by Statins Decreases Intra-Ocular Pressure. Should We...
Healthcare and Medical Sciences
Clinical application of cardiovascular pharmacogenetics
Clinical application of cardiovascular pharmacogenetics
Gowhar Shafi
PLATINUM DRUGS PRESENTATION
PLATINUM DRUGS PRESENTATION
Sudeshna Biswas
JCP/?PRESENTATION IN A JOURNAL CLUB.....
JCP/?PRESENTATION IN A JOURNAL CLUB.....
Dr. Ajit Surya Singh
SIP Poster - Sarah Sugarman
SIP Poster - Sarah Sugarman
Sarah Sugarman
Medicinal application of organometallic compounds
Medicinal application of organometallic compounds
ALIRAZA2498
P. KurunwuneLinkedin-pitavastatin
P. KurunwuneLinkedin-pitavastatin
Patrick Kurunwune
Statins and its pleiotropic effects 2
Statins and its pleiotropic effects 2
AakankshaPriya1
Ezzahti sijbrands mulder roeters van lennep familial hypercholesterolemia new...
Ezzahti sijbrands mulder roeters van lennep familial hypercholesterolemia new...
Marilyn Mann
J Biomol Screen-2013-Maillard-868-78 (dragged)
J Biomol Screen-2013-Maillard-868-78 (dragged)
Hyunsun Park
bradykinin receptor antagonist and thrombin inhibitors
bradykinin receptor antagonist and thrombin inhibitors
BhanuSri28
Ähnlich wie Rosuvastatin, pcsk9 concentrations, and ldl cholesterol response the jupiter trial
(20)
Chasman
Chasman
Immunocal Lung Cancer Ars
Immunocal Lung Cancer Ars
3-D QSAR studies on maslinic acid analogs
3-D QSAR studies on maslinic acid analogs
Nrcar interactive dyslipidaemia_poster
Nrcar interactive dyslipidaemia_poster
Nrcar dyslipidaemia poster_web
Nrcar dyslipidaemia poster_web
Pcsk9 inhibitors thesis defence
Pcsk9 inhibitors thesis defence
Target ldl levels in extreme high risk acs. acheiving the goal
Target ldl levels in extreme high risk acs. acheiving the goal
Shu
Shu
Drug drug gene interactions
Drug drug gene interactions
KATP Channel Activation by Statins Decreases Intra-Ocular Pressure. Should We...
KATP Channel Activation by Statins Decreases Intra-Ocular Pressure. Should We...
Clinical application of cardiovascular pharmacogenetics
Clinical application of cardiovascular pharmacogenetics
PLATINUM DRUGS PRESENTATION
PLATINUM DRUGS PRESENTATION
JCP/?PRESENTATION IN A JOURNAL CLUB.....
JCP/?PRESENTATION IN A JOURNAL CLUB.....
SIP Poster - Sarah Sugarman
SIP Poster - Sarah Sugarman
Medicinal application of organometallic compounds
Medicinal application of organometallic compounds
P. KurunwuneLinkedin-pitavastatin
P. KurunwuneLinkedin-pitavastatin
Statins and its pleiotropic effects 2
Statins and its pleiotropic effects 2
Ezzahti sijbrands mulder roeters van lennep familial hypercholesterolemia new...
Ezzahti sijbrands mulder roeters van lennep familial hypercholesterolemia new...
J Biomol Screen-2013-Maillard-868-78 (dragged)
J Biomol Screen-2013-Maillard-868-78 (dragged)
bradykinin receptor antagonist and thrombin inhibitors
bradykinin receptor antagonist and thrombin inhibitors
Kürzlich hochgeladen
Falcon Invoice Discounting: Empowering Your Business Growth
Falcon Invoice Discounting: Empowering Your Business Growth
Falcon investment
Lucknow Housewife Escorts by Sexy Bhabhi Service 8250092165
Lucknow Housewife Escorts by Sexy Bhabhi Service 8250092165
meghakumariji156
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Tim Wilson
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
daisycvs
Nashik Call Girl Just Call 7091819311 Top Class Call Girl Service Available
Nashik Call Girl Just Call 7091819311 Top Class Call Girl Service Available
pr788182
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
allensay1
Cannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 Updated
CannaBusinessPlans
Falcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting
PHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation Final
PanhandleOilandGas
JAJPUR CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN JAJPUR ESCORTS
JAJPUR CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN JAJPUR ESCORTS
kajalroy875762
Mckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for Viewing
Nauman Safdar
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
pr788182
Phases of Negotiation .pptx
Phases of Negotiation .pptx
nandhinijagan9867
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
ssuserf63bd7
Falcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business Potential
Falcon investment
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
NadhimTaha
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Adnet Communications
Berhampur CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
pr788182
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
pr788182
Putting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptx
Cynthia Clay
Kürzlich hochgeladen
(20)
Falcon Invoice Discounting: Empowering Your Business Growth
Falcon Invoice Discounting: Empowering Your Business Growth
Lucknow Housewife Escorts by Sexy Bhabhi Service 8250092165
Lucknow Housewife Escorts by Sexy Bhabhi Service 8250092165
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
Nashik Call Girl Just Call 7091819311 Top Class Call Girl Service Available
Nashik Call Girl Just Call 7091819311 Top Class Call Girl Service Available
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
Cannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 Updated
Falcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investors
PHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation Final
JAJPUR CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN JAJPUR ESCORTS
JAJPUR CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN JAJPUR ESCORTS
Mckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for Viewing
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Phases of Negotiation .pptx
Phases of Negotiation .pptx
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
Falcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business Potential
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Berhampur CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Putting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptx
Rosuvastatin, pcsk9 concentrations, and ldl cholesterol response the jupiter trial
1.
Rosuvastatin, Proprotein Convertase Subtilisin/Kexin
Type 9 Concentrations, and LDL Cholesterol Response: the JUPITER Trial Z. Awan, N.G. Seidah, J.G. MacFadyen, S. Benjannet, D.I. Chasman, P.M. Ridker, and J. Genest January 2012 www.clinchem.org/content/58/1/183.full © Copyright 2012 by the American Association for Clinical Chemistry
2.
Introduction PCSK9 function
PCSK9 is a protein secreted predominantly by the liver that has a substantial effect on LDL-C concentration PCSK9 has both an active form and an inactive (furin cleaved) form circulating in the blood Gain-of-function and loss-of-function mutations in PCSK9 gene cause a high and low LDL-C phenotype, respectively The mechanism is not fully understood, but it is thought that PCSK9 promotes degradation of the LDL receptor © Copyright 2009 by the American Association for Clinical Chemistry
3.
Introduction (cont’d) PCSK9
regulation Both the LDL receptor and PCSK9 are up regulated by statins through sterol regulatory element binding protein-2 (SREBP-2) ti l ti (SREBP 2) stimulation PCSK9 targeting Given these interrelationships, there has been considerable interest in understanding the effect of statins on PCSK9 concentrations, particularly since agents designed to inhibit p y g g PCSK9 are likely to be used as adjuncts to statin therapy Phase II and III clinical trials are currently being conducted using PCSK9 antisense and inhibitors to lower LDL-C g © Copyright 2009 by the American Association for Clinical Chemistry
4.
Questions
Is there a difference in mean PCSK9 concentration between men and women? Is the PCSK9 concentration stable over time? What is the relation between LDL-C reduction and PCSK9 concentration after a dose of 20mg rosuvastatin? © Copyright 2009 by the American Association for Clinical Chemistry
5.
Method PCSK9 measurement
Total plasma PCSK9 concentration was measured by ELISA at baseline and after one year in 500 men and 500 women participating in the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin ( (JUPITER) trial that randomly allocated p ) y participant to p rosuvastatin 20 mg daily or placebo >Genetic evaluation rs11591147 (R46L), a single nucleotide polymorphism known to have a lowering effect on plasma PCSK9 concentrations, was evaluated © Copyright 2009 by the American Association for Clinical Chemistry
6.
Results R
lt Table 1. a Data are median (25th–75th percentile) or n (%). No statistical difference exists between the 2 groups in either sex (n = 250 in each gro p) se group). b As defined by the consensus criteria of the American Heart Association. © Copyright 2009 by the American Association for Clinical Chemistry
7.
Results ( R
lt (cont’d) t’d) © Copyright 2009 by the American Association for Clinical Chemistry
8.
Results ( R
lt (cont’d) t’d) Figure 1. Stability of PCSK9 concentrations over 1 year in the JUPITER placebo arm vs the rosuvastatin arm. PCSK9 concentrations in men and women at baseline and over 1 year. Vertical bars minimum and maximum values; box interquartile range (IQR); horizontal bar median; NS bars, box, bar, NS, nonsignificant; t=0, baseline values; t=12, 1-year values. *P 0.0001. © Copyright 2009 by the American Association for Clinical Chemistry
9.
Questions
Can PCSK9 concentrations be used to determine LDL-C response to statins? Will carriers of the SNP (R46L) respond better to rosuvastatin 20mg than non carriers? © Copyright 2009 by the American Association for Clinical Chemistry
10.
Results ( R
lt (cont’d) t’d) Figure 1 suppl. (A), Correlation between baseline LDL-C and PCSK9 values in the placebo and rosuvastatin arm. (B), After one year in the rosuvastatin arm (disruption of correlation). © Copyright 2009 by the American Association for Clinical Chemistry
11.
Results R
lt (cont’d) Figure 2. Rosuvastatin increased plasma concentrations of PCSK9 in proportion to the magnitude of LDL-C reduction. (A), Individual percentage LDL-C change in response to rosuvastatin ranked by magnitude of effect. (B), Corresponding change in PCSK9 concentrations for each study subject ranked by the magnitude of LDL-C change. (C), Changes in PCSK9 ranked by quintiles of LDL-C change on rosuvastatin. (D), LDL-C percentage change on rosuvastatin correlates significantly with PCSK9 percentage change. © Copyright 2009 by the American Association for Clinical Chemistry
12.
Results ( R
lt (cont’d) t’d) Figure 2 suppl. (A), Baseline PCSK9 values in the placebo and rosuvastatin arm for men and women separately (n=954). (B), LDL-C reduction after one year on the rosuvastatin arm for men and women together (n=478). © Copyright 2009 by the American Association for Clinical Chemistry
13.
Summary
This study is the largest to demonstrate that rosuvastatin at a 20 mg dosage increases plasma concentrations of PCSK9 by 28% and 34% in men and women, respectively Women have a higher baseline concentration than men and this difference is exaggerated further when 20 mg rosuvastatin is given Circulating PCSK9 as a biomarker is stable over time in apparently healthy individuals © Copyright 2009 by the American Association for Clinical Chemistry
14.
Summary (cont’d)
Carriers of the SNP (R46L) respond similarly to rosuvastatin LDL-C reduction as non carriers Total PCSK9 concentrations cannot be used to determine individual LDL-C response to rosuvastatin Rosuvastatin use was not associated with LDL- LDL C response blunting as the PCSK9 concentration increased © Copyright 2009 by the American Association for Clinical Chemistry
15.
Discussion Statin effect
on PCSK9 There is a need to understand the paradoxical relationship between statin-mediated PCSK9 increase and LDL-C. A ratio between PCSK9 active and inactive forms may be the key for understanding this relationship. A strategy based on the measurement of LDL-C response and PCSK9 concentrations may help identify those statin-resistant subjects with increased PCSK9 statin resistant concentration whom may benefit from PCSK9 modulation. © Copyright 2009 by the American Association for Clinical Chemistry
16.
Thank you for
participating in this month’s Clinical Chemistry Journal Club. Additional Journal Clubs are available at www.clinchem.org Follow us © Copyright 2009 by the American Association for Clinical Chemistry
Jetzt herunterladen